¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • R89.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
  • T44.4
    Predominantly ¥á-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î ¾ËÆÄ¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
  • T44.5
    Predominantly ¥â-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î º£Å¸¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
  • T45.3
    Enzymes, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº È¿¼Ò
  • T46.4
    Angiotensin-converting-enzyme inhibitors
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦Á¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á